IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
39,89Â US$
0,00%
(0,00) 1D
6 tet, 3:05:13 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për IPSEY...
Kapitalizimi i tregut
11,93Â mld
Vëllimi mesatar
842,00
Vëllimi
0,00
Maksimumi 52-javor
51,10Â US$
Minimumi 52-javor
32,68Â US$
Beta
0,41
Aksionet në qarkullim
335,26Â mln
Numri i punonjësve
6 mijë
Kapitalizimi i tregut
11,93Â mld
Vëllimi mesatar
842,00
Vëllimi
0,00
Maksimumi 52-javor
51,10Â US$
Minimumi 52-javor
32,68Â US$
Beta
0,41
Aksionet në qarkullim
335,26Â mln
Numri i punonjësve
6 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Ideal Investisseur
·
1 orë më parë
Weighed Down by 13% in One Month, Ipsen Stock Declines Further Following Jefferies Downgrade
TipRanks
·
18 orë më parë
Ipsen Reports September 2026 Share Capital and Voting Rights
Stock Titan
·
19 orë më parë
Some Ipsen shares count twice: 83.8 million shares came with 132 million votes.
Profili
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
Rreth Ipsen ADR Rep 1/4 Ord Shs